Consistent with these findings, compared to their TIM-3- counterparts, PD-1+TIM-3+ CD8 T cells from RCC tumors were shown to respond poorly to anti-CD3 and anti-CD28 stimulation as measured by IFNγ secretion. Here, CD28 is linked to renal cell carcinoma.